Comparative analysis of p-AURKA/AURKA between normal samples and all cancer tumors indicated a 3.43-fold and 3.12-fold enhancement of protein level in the CRC group and lung cancer group, respectively (P < 0.001). This evidence concerns the gene AURKA and colorectal carcinoma.